The Protection, Health and Care Conference is an annual conference aimed at all insurance professionals with a passion for harnessing insurance risk in their organisations. The conference uses a combination of workshops by individuals who work at the coalface and ‘big name’ experts to explore how innovation, technological/medical advances, the political landscape and other market development will impact the Protection, Health and Care markets.
Recordings of webinars can be purchased by visiting our Online Learning Resource page covering health and care.
Video costs: Members £15.00 | Non-Members £35
Although primarily aimed at actuaries, the webinars may also be of value to others who have an interest in Protection, Health and Care.
|Non - member||£35|
Contact Events Team for more information.
0207 632 1498
|10 June 2020|
12.00 - 13.00: CMI Update
An update from the Continuous Mortality Investigation (CMI) with content focused on the work of the Assurances Committee and the Income Protection Committee.
Speakers: Duncan Heald and Hamish Wilson, CMI
If you missed the webinar, a recording is available to purchase.
|23 June 2020|
A prospective research study - the first to look at an insured population sample - designed to test whether psychosocial factors predict return to work in disability claims.
Speaker: Stephanie McCahon and Nisha Price, Swiss Re
|25 June 2020|
In this session we will present the results of an international survey of claims assessors. Bringing out key similarities and differences in claims practices in different locations and their impact on the management of disability claims.
Speakers: Clio Lawrence and Mary Enslin, Gen Re
|08 July 2020|
13.00 - 14.00: Building a Shiny Death Toolbox
An overview of how and why we built a Death Toolbox using Shiny. This includes a live demonstration of the tool that enables a user to explore mortality datasets without knowing specialist coding techniques.
Speakers: Chris Reynolds and Florian Gomez, Partner Re
|20 July 2020|
14.00 - 15.00: Impactability Modelling for Population Health Management
Population Health Management considers the distribution of health outcomes within a population and how to impact these outcomes in the most optimal way for the group as a whole. The initial report of the Working Party focusses on the specific topic of impactability modelling, an area where actuarial skills can help bring insight to some of the strategic challenges the NHS and other health systems are facing. This session will provide an overview of the working party's research including defining impactability and impactability modelling, discussing some examples of specific modelling approaches, considering the practical challenges across the NHS as well as wider public perception and ethical issues.
Speakers: Alpesh Shah, PwC and David Beddows, Optum
|28 July 2020|
15.00 - 16.00: Dementia and insurance: cognitive protection
With the rising prevalence of dementia, how can we manage this risk effectively and can insurance do more?
In 2025, the number of people living with dementia in the UK will pass one million. But yet incidence has fallen at all ages in recent years. How well do we understand the diseases which cause dementia? Can we predict who might develop dementia? What is technology's role? Matt Singleton, Ageing Lead at Swiss Re, will cover these topics and how insurance could help people address their concerns.
Speaker: Matthew Singleton, Swiss Re
|04 August 2020|
Traditional approaches to mental health underwriting are based on historic data and medical practices. These practices have moved on significantly, impacting on how we interpret historic data and the impact on future mortality and morbidity.
This session will cover how we have challenged conventional approaches to underwriting and risk selection to develop an approach that aligns current practices, customer and broader interests with robust risk assessment.
Speaker: Scott Cadger, Lloyds Banking Group
|05 August 2020|
10.00 - 11.00: Engagement and innovation for the next generation consumer
Using new and unique research and data from the UK, US, Sweden and China, this presentation investigates how consumers use the internet through their insurance journey and analyzes the role culture and generation plays in their online behaviour. We use this research to show the online landscape for insurance sales in the UK and suggest ways to shape new products and effectively engage with the consumer who is buying them.
Speakers: Chloe Gilbert, Swiss Re and Sophia Steinmetz
|06 August 2020|
10.00 - 11.00: Gene Modification
CMO Dr O'Brien will discuss the impacts of Gene Modification for life/health insurance.
Affordable gene sequencing and initiatives such as the 100 000 genome project, have provided information on genetic links to many diseases. Precise gene abnormalities for previously described genetic diseases can now be identified. This identification can facilitate avoidance of these conditions by pre-implantation diagnosis. The next step is to see how these genes can be manipulated to correct the abnormalities. Exciting techniques such as CRISPR and viral vectors show promise in treating some serious and devastating diseases. The ability to change genes does however predictably pose ethical dilemmas
Speaker: Dr John O’Brien, Gen Re
|11 August 2020|
|12 August 2020|
Modelling the structure and trends of cancer morbidity risk is important for pricing and reserving in related health insurance fields such as critical illness insurance and care provision. We model the dynamics of cancer incidence over time in different regions in England, using 1981-2016 ONS data. The modelling allows estimation of cancer rates at various age, year, gender and region levels, following a Bayesian setting to account for statistical uncertainty. Our analysis indicates significant regional variation in cancer incidence rates.
Speaker: George Streftaris, Heriot-Watt University
|13 August 2020|
The PRA have made clear their expectation that climate change will be mainstreamed in insurance businesses’ risk frameworks. The first step in this journey is to measure exposure to climate changes’ many aspects and disclose them – even if only internally!
In this talk we will outline the steps Aviva took in pulling together our first large-scale disclosures on the exposure of our business to climate change published in March 2019; in line with the recommendations of the Taskforce on Climate-related Financial Disclosures. After touching on why insurers have such an important role in climate change, we'll cover a brief “how-to” guide for those who have not yet embarked on thinking about these topics before giving a case study of how the learnings from a TCFD disclosure exercise can be applied to investment portfolios.
Speaker: Russ Bowdrey, Aviva
|17 August 2020|
12.00 - 13.00: Can we manage Diabetes risk for healthier outcomes
The insurance industry currently underwrites customers with diabetes based on a range of factors, medical expertise and various medical studies. The work undertaken by the WP would help the industry to approach this using current research findings to update and enhance how potential risk from diabetes is considered. This includes the need to understand the underwriting implications as treatments improve, and potentially to develop new products that are tailored to those with diabetes. The WP will present our latest findings in the management of this important chronic condition which will include research in collaboration with the ARC.
Speakers: Scott Reid, Zurich and Nicola Oliver, Medical Intelligence